Nucleotide sequences that distinguish Oka vaccine from parental Oka and other Varicella-Zoster virus isolates

Journal of Infectious Diseases

Volumn 181, Issue 3, 2000, Pages 1153-1157

  Argaw, Takele ^a   Cohen, Jeffrey I ^b   Klutch, Michael ^a   Lekstrom, Kristen ^b   Yoshikawa, Tetsushi ^c   Asano, Yoshizo ^c   Krause, Philip R ^a,d  

^a Division of Viral Products   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VARICELLA ZOSTER VIRUS; VIRUS ISOLATION;

BASE SEQUENCE; CHICKENPOX VACCINE; HERPESVIRUS 3, HUMAN; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; VACCINES, SYNTHETIC;

EID: 0034117538     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315335     Document Type: Article

References (18)

1. 1. Cohen JI, Brunell PA, Straus SE, Krause PR. NIH conference: recent advances in varicella-zoster virus infection. Ann Intern Med 1999;130: 922-32.
2. 2. Krause PR, Klinman DM. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr 1995;127:518-25.
3. 3. Takahashi M, Otsuka T, Okuno Y. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-90.
4. 4. Hughes P, LaRussa P, Pearce JM, LePow M, Steinberg S, Gershon A. Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction. J Pediatr 1994;124:932-5.
5. 5. Salzman MB, Sharrar RG, Steinberg S, LaRussa P. Transmission of varicella-vaccine virus from a healthy 12-month old child to his pregnant mother. J Pediatr 1997;131:151-4.
6. 6. Tsolia M, Gershon AA, Steinberg SP, Gelb L. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of the varicella-zoster virus. J Pediatr 1990;116: 184-9.
7. 7. LaRussa P, Steinberg S, Meurice F, Gershon A. Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts. J Infect Dis 1997;176:1072-5.
8. 8. Brunell PA, Geiser CF, Novelli V, Lipton S, Narkewicz S. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia. Pediatrics 1987;79:922-7.
9. 9. Hayakawa Y, Torigoe S, Shiraki K, Yamanishi K, Takahashi M. Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients. J Infect Dis 1984;149: 956-63.
10. 10. Hawrami K, Breuer J. Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain. J Med Virol 1997;53:60-2.
11. 11. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg S, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 1992;66:1016-20.
12. 12. LaRussa P, Steinberg S, Arvin A, et al. Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J Infect Dis 1998;178:S64-6.
13. 13. Mori C, Takahara R, Toriyama T, Nagai T, Takahashi M, Yamanishi K. Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis. J Infect Dis 1998;178:35-8.
14. 14. Takada M, Suzutani T, Yoshida I, Matoba M, Azuma M. Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region. J Clin Microbiol 1995;33:65-60.
15. 15. Cohen JI, Seidel KE. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci USA 1993;90:7376-80.
16. 16. Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986;67:1759-816.
17. 17. Perera LP, Mosca JD, Ruyechan WT, Hay J. Regulation of varicella-zoster virus gene expression in human T lymphocytes. J Virol 1992;66:5298-304.
18. 18. Tyler JK, Allen KE, Everett RD. Mutation of a single lysine residue severely impairs the DNA recognition and regulatory functions of the VZV gene 62 transactivator protein. Nucleic Acids Res 1994;22:270-8.